● Recruiting

A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis

Condition: Juvenile Psoriatic Arthritis · Sponsor: Bristol-Myers Squibb

PhasePhase 3

Planned participants60

Who can joinAll sexes, 5 Years to 17 Years

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the drug levels, efficacy, and safety of Deucravacitinib (BMS-986165) in pediatric participants with juvenile psoriatic arthritis.

This description comes directly from the study's public registry record.

Talk to the study team

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Always discuss trial participation with your own doctor first.

Locations (47)

Local Institution - 0038	Lancaster, California, United States	Withdrawn
Local Institution - 0020	Chicago, Illinois, United States	Withdrawn
Local Institution - 0023	Indianapolis, Indiana, United States	Withdrawn
Local Institution - 0059	North New Hyde Park, New York, United States	Withdrawn
Local Institution - 0065	Cincinnati, Ohio, United States	Withdrawn
Local Institution - 0066	Cleveland, Ohio, United States	Withdrawn
Local Institution - 0036	Austin, Texas, United States	Withdrawn
Centro de Oncologia Leonardo Da Vinci - ATO Terapias	Fortaleza, Ceará, Brazil	Recruiting
Local Institution - 0032	Cuiabá, Mato Grosso, Brazil	Withdrawn
Santa Casa de Misericordia de Belo Horizonte	Belo Horizonte, Minas Gerais, Brazil	Recruiting
Local Institution - 0013	Curitiba, Paraná, Brazil	Withdrawn
Local Institution - 0072	Curitiba, Paraná, Brazil	Not Yet Recruiting

+ 35 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06869551